Article
Phenotype of BTK-lacking myeloid cells during prolonged COVID-19 and upon convalescent plasma.
European journal of haematology - 1 Feb 2023
Gomes André M C, Farias Guilherme B, Trombetta Amelia C, Godinho-Santos Ana, Parreira Inês, Gonçalves Hélder Diogo, Simões Mariana Lessa, Aguiar Patrício, Deveza Maria Manuel, Inácio João, Sousa Ana E, da Silva Susana Lopes
Abstract excerpt
XLA patient with 7-month course of COVID-19 with persistent plasma SARS-CoV-2 load revealed a sustained non-inflammatory profile of myeloid cells in association with contained severity of disease, arguing in favor of the use of BTK inhibitors in SARS-COV-2 infection.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.